Tuesday, September 12, 2006

OTC BB Press Releases - September 12, 2006 (part 2)

ALRX:OB - AlphaRx Receives Notice of Allowance From the US Patent Office

ARFR:OB - Preclinical Studies Underway on Advanced Refractive Technologies Novel Glaucoma Treatment

ABAT:OB - Advanced Battery Technologies, Inc. Received Order of 300,000 Mine Lamp PLI Battery Cells

AGXM:OB - Argentex announces additional 2006 drill results, updates progress at Pinguino, Argentina

CDGT:OB - WallStreet Research Continues Coverage of China Digital Media Corporation's Shares With a Speculative Buy Recommendation at Http://www.WallStreetResearch.org

CHCG:OB - China 3C Group Signs Agreement With China Unicom

CMNN:OB - Communicate.com Inc.: Importers.com Signs Sales and Marketing Agreement for China

CNTE:OB - WallStreetSavant.com Announces Profile Coverage of California News Tech

DRGG:OB - Dragon International Group Corp. Announces Schedule of Investor Meetings

DSSI:OB - Comverge Announces Support for DOE/EPA National Action Plan for Energy Efficiency and Demand Response

MKOS:OB - John Barnett Named as Director of Business Development for Manakoa

NNPP:OB - Nano-Proprietary, Inc. Awarded Homeland Security Contract for Cargo Shipping Container Sensor

NVAS:OB - Thorium Power Receives Endorsement from International Experts

PHFB:OB - Phantom Fiber Launches Another Five New Brands On Its Advanced Mobile Framework

RGBL:OB - RG Global Lifestyles Schedules Launch of Aquair's New 'OC ENERGY' Drinks and their 100% Pure Oxygenated Water Featuring the 'OC Angels' as Spokespersons

STTC:OB - SoftNet Technology Strengthens Management Team Adds Two Senior Executives

URME:OB - Uranium Energy Corp Announces Phase I Drilling Results from its Goliad Project in South Texas

VEII:OB - Voyager Entertainment International Receives $1.25M in Funding and Completes the Acquisition of Western Architectural Services

VITS:OB - Vitasti Completes Private Placement for Zhanjiang Wind Farm

VQPH:OB - VioQuest Pharmaceuticals Doses First Patient in Phase I/IIa Clinical Trial With VQD-002 (Triciribine-Phosphate) for Treatment of Leukemia

WSCE:OB - Wescorp Establishes a Business Presence in Texas

XSNX:OB - XsunX Achieves Milestone in Development of Power Glass Thin Films

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home